← Explorer/Network

Therapeutic potential of TGF-β-induced CD4+Foxp3+regulatory T cells in autoimmune diseases

Zhou X, Kong N, Zou H +4 more2011AutoimmunityReview
10.3109/08916931003782163PubMedFree full text
Immune/Innate

Abstract

Foxp3(+) T regulatory cell (Treg) subsets play a crucial role in the maintenance of immune homeostasis against self-antigens. The lack or dysfunction of these cells contributes to the pathogenesis and development of many autoimmune diseases. Therefore, manipulation of these cells may provide a novel therapeutic approach to treat autoimmune diseases. In this review, we provide current opinions concerning the classification, developmental, and functional characterization of Treg subsets. Particular emphasis will be focused on the therapeutic role of TGF-β-induced CD4M(+) Foxp3(+) cells (iTregs) in established autoimmune disease. Moreover, the similarity and diversity of iTregs and naturally occurring, thymus-derived CD4(+) CD25(+) Foxp3(+) regulatory T cells (nTregs) will be discussed, including the finding that the pro-inflammatory cytokine IL-6 can convert nTregs to IL-17-producing cells, whereas iTregs induced by TGF-β are resistant to the effects of this cytokine. Understanding these aspects may help to determine how Tregs can be used in the treatment of autoimmune diseases.

Key Biomarkers

CD4+ Foxp3+ regulatory T cellsIL-17IL-6TGF-beta

Symptom Clusters

Autoimmune disease pathogenesis

Cited By (1)

  • Function and Role of Regulatory T Cells in Rheumatoid ArthritisFrontiers in Immunology · 2021

References (12)

  • Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity: The Role of IL-2, TGF-β, and IL-10The Journal of Immunology · 2004
  • Cutting Edge: Foxp3+CD4+CD25+ Regulatory T Cells Induced by IL-2 and TGF-β Are Resistant to Th17 Conversion by IL-6The Journal of Immunology · 2008
  • Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3The Journal of Experimental Medicine · 2003
  • The Foxp3+ regulatory T cell: a jack of all trades, master of regulationNature Immunology · 2008
  • A Role for TGF-β in the Generation and Expansion of CD4+CD25+ Regulatory T Cells from Human Peripheral BloodThe Journal of Immunology · 2001

Related Papers

  • Pro-resolving and anti-arthritic properties of the MC1 selective agonist PL8177Frontiers in Immunology · 2022 · 1 shared tag
  • Effects of Omega-3 Polyunsaturated Fatty Acids on the Formation of Adipokines, Cytokines, and Oxylipins in Retroperitoneal Adipose Tissue of MiceInternational Journal of Molecular Sciences · 2024 · 1 shared tag
  • Fungal immunity and pathogenesis in mammals versus the invertebrate model organismGalleria mellonellaPathogens and Disease · 2021 · 1 shared tag
  • TLR signaling pathway and the effects of main immune cells and epigenetics factors on the diagnosis and treatment of infertility and sterilityHeliyon · 2024 · 1 shared tag
  • CGRP sensory neurons promote tissue healing via neutrophils and macrophagesNature · 2024 · 1 shared tag
  • Invited review: Mechanisms of hypophagia during diseaseJournal of Dairy Science · 2021 · 1 shared tag
Generation Ex Vivo of TGF-β-Producing Regulatory T Cells from CD4+CD25− Precursors
The Journal of Immunology · 2002
  • TGF-β Requires CTLA-4 Early after T Cell Activation to Induce FoxP3 and Generate Adaptive CD4+CD25+ Regulatory CellsThe Journal of Immunology · 2006
  • Natural and TGF-β–induced Foxp3+CD4+ CD25+ regulatory T cells are not mirror images of each otherTrends in Immunology · 2008
  • Transforming growth factor-β1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host diseaseBritish Journal of Dermatology · 2008
  • DNA methylation controls Foxp3 gene expressionEuropean Journal of Immunology · 2008
  • Activation-induced FoxP3 in human T effector cells does not suppress proliferation or cytokine productionInternational Immunology · 2007
  • Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune diseaseSeminars in Immunology · 2004